Literature DB >> 15575855

Efficacy of a reduced application time of Ovide lotion (0.5% malathion) compared to Nix creme rinse (1% permethrin) for the treatment of head lice.

Terri L Meinking1, Maureen Vicaria, Deborah H Eyerdam, Maria Elena Villar, Susan Reyna, German Suarez.   

Abstract

Our objective was to conduct a randomized, investigator-blinded evaluation of the pediculicidal and ovicidal activity of a reduced application time (20 minutes) of Ovide (0.5% malathion) compared to Nix (1% permethrin) in a south Florida population infested with Pediculus humanus capitis. Either Ovide or Nix was applied according to the label instructions. However, Ovide application time was reduced to 20 minutes. At day 8, subjects with live lice were re-treated with the same product and procedure as on day 1. Ovicidal and pediculicidal efficacy were evaluated at days 8 and 15. A subject free of lice and viable eggs at day 15 was considered to be a treatment success. Percent efficacy was calculated using the number of subjects free of lice and viable eggs per total number of subjects treated. We found that a 20-minute application of Ovide was significantly more pediculicidal and ovicidal (98%) compared to Nix (55%) at day 15 (p < 0.0001). The percentage of Ovide subjects who required treatment at day 8 was half that of the Nix group. The reinfestation rate was 0% with Ovide and 33% with Nix. In conclusion, a 20-minute treatment with Ovide, instead of the approved 8- to 12-hour application, cured 40 of 41 subjects (98%), demonstrating superior efficacy to Nix. The poor efficacy of Nix confirms the resistance of head lice to permethrin in south Florida.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15575855     DOI: 10.1111/j.0736-8046.2004.21613.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  10 in total

Review 1.  [Mites, lice and fleas. Ectoparasitoses in infancy and childhood].

Authors:  H Hamm
Journal:  Hautarzt       Date:  2005-10       Impact factor: 0.751

Review 2.  Head lice.

Authors:  Ian F Burgess
Journal:  BMJ Clin Evid       Date:  2011-05-16

3.  Cutaneous infections and infestations: new therapies.

Authors:  Emily C Keller; Kenneth J Tomecki
Journal:  J Clin Aesthet Dermatol       Date:  2011-12

4.  Ex vivo effectiveness of French over-the-counter products against head lice (Pediculus humanus capitis De Geer, 1778).

Authors:  Catherine Combescot-Lang; Robert H Vander Stichele; Berthine Toubate; Emilie Veirron; Kosta Y Mumcuoglu
Journal:  Parasitol Res       Date:  2015-02-27       Impact factor: 2.289

Review 5.  Head lice.

Authors:  Ian F Burgess
Journal:  BMJ Clin Evid       Date:  2009-01-14

6.  Head lice treatments and school policies in the US in an era of emerging resistance: a cost-effectiveness analysis.

Authors:  Itzhak Gur; Ronald Schneeweiss
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

7.  A comparative analysis of the Libyan national essential medicines list and the WHO model list of essential medicines.

Authors:  Asma Abubakr Mustafa; Stefan Robert Kowalski
Journal:  Libyan J Med       Date:  2010-12-02       Impact factor: 1.657

Review 8.  Treatment of Pediculosis Capitis.

Authors:  Prashant Verma; Chaitanya Namdeo
Journal:  Indian J Dermatol       Date:  2015 May-Jun       Impact factor: 1.494

Review 9.  Management and Treatment of Human Lice.

Authors:  Abdoul Karim Sangaré; Ogobara K Doumbo; Didier Raoult
Journal:  Biomed Res Int       Date:  2016-07-27       Impact factor: 3.411

10.  Expansion of the Knockdown Resistance Frequency Map for Human Head Lice (Phthiraptera: Pediculidae) in the United States Using Quantitative Sequencing.

Authors:  Kyle J Gellatly; Sarah Krim; Daniel J Palenchar; Katie Shepherd; Kyong Sup Yoon; Christopher J Rhodes; Si Hyeock Lee; J Marshall Clark
Journal:  J Med Entomol       Date:  2016-03-31       Impact factor: 2.278

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.